Fig. 1

Sequential delivery is effective across all CPP types. Polymer dose-dependent uptake of the MK2i peptide (co-delivery of pre-complexed polymer/peptide) fused to a three separate cationic, non-amphipathic CPPs and b two different amphipathic CPPs. Sequential polymer then peptide delivery polymer dose-dependent uptake of the MK2i peptide fused to c three separate cationic, non-amphipathic CPPs and d two different amphipathic CPPs. e Polymer dose-dependent uptake of the YARA CPP fused to two separate therapeutic peptide sequences (MK2i and VASP) when co-delivered. f Polymer dose-dependent uptake of the VASP peptide without a CPP. The mass ratios used for all data shown are 3:1, 1:1, 1:3, 1:5, 1:10, and 1:20 peptide:polymer. Error bars represent SEM. Non-normalized uptake for all data presented in this figure is shown in Supplementary Fig. 4